Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Short-term Investments: 2020-2024

Historic Short-term Investments for Ani Pharmaceuticals (ANIP) over the last 4 years, with Dec 2024 value amounting to $33,000.

  • Ani Pharmaceuticals' Short-term Investments rose 2.86% to $36,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $36,000, marking a year-over-year increase of 2.86%. This contributed to the annual value of $33,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Short-term Investments is $33,000, which was down 99.34% from $5.0 million recorded in FY2022.
  • Ani Pharmaceuticals' Short-term Investments' 5-year high stood at $5.0 million during FY2022, with a 5-year trough of $33,000 in FY2024.
  • For the 2-year period, Ani Pharmaceuticals' Short-term Investments averaged around $2.5 million, with its median value being $2.5 million (2022).
  • Its Short-term Investments has fluctuated over the past 5 years, first dropped by 0.04% in 2021, then increased by 0.10% in 2022.
  • Yearly analysis of 4 years shows Ani Pharmaceuticals' Short-term Investments stood at $5.0 million in 2020, then decreased by 0.04% to $5.0 million in 2021, then climbed by 0.10% to $5.0 million in 2022, then reached $33,000 in 2024.